Group B streptococcus (GBS) vaccine

BIOLOGICAL2 trials

Sponsors

Novartis, Novartis Vaccines

Conditions

Group B Streptococcus (GBS) Disease

Phase 1

A Study to Assess the Persistence of a GBS Antibody in Women Previously Immunized With a GBS Vaccine

CompletedNCT01052935

NovartisGroup B Streptococcus (GBS) Disease

Start: 2010-01-31End: 2010-10-31Updated: 2017-06-14

A Study to Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS Vaccine

CompletedNCT01053767

Novartis VaccinesGroup B Streptococcus (GBS) Disease

Start: 2010-01-31End: 2010-12-31Updated: 2020-02-11